Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wilate in children <6 years with severe von Willebrand disease
NCT04953884Phase 3Completed
- Sponsor
- Octapharma
- Start
- Sep 2021
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of von Willebrand factor concentrate in von Willebrand disease (VWD), sponsored by Octapharma. Started Sep 2021; status: completed.
02
Drugs
von Willebrand factor concentrate
03
Conditions
von Willebrand disease (VWD)
Beyond the preview
Go deeper on NCT04953884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04953884.